Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited (APOLLOHOSP) financial statements and selected valuation metrics from NSE/BSE exchange filings through 30 June 2026.
Healthcare›Healthcare›Healthcare Services›Hospital
apollohospitals.com(opens the company website in a new tab)Key metrics
Price as of 2026-09-03
Sign in for full ratios and TTM. Learn about these metrics →
Share price
NSE closing price from historical market data.
Loading price history…
Statement tables · Consolidated
Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.
Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows
Quarterly results
Quarterly · ₹ Cr · tap + rows to expand
| Metric | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4,847 Cr | 4,851 Cr | 4,944 Cr | 5,086 Cr | 5,589 Cr | 5,527 Cr | 5,592 Cr | 5,842 Cr | 6,304 Cr | 6,477 Cr | 6,606 Cr | 7,044 Cr |
| Operating expenses (approx.) | 4,219 Cr | 4,237 Cr | 4,303 Cr | 4,411 Cr | 4,774 Cr | 4,765 Cr | 4,823 Cr | 4,990 Cr | 5,362 Cr | 5,512 Cr | 5,595 Cr | 5,951 Cr |
| EBITDA | 628 Cr | 614 Cr | 641 Cr | 675 Cr | 816 Cr | 762 Cr | 770 Cr | 852 Cr | 941 Cr | 965 Cr | 1,011 Cr | 1,092 Cr |
| OPM % | 12.9% | 12.7% | 13.0% | 13.3% | 14.6% | 13.8% | 13.8% | 14.6% | 14.9% | 14.9% | 15.3% | 15.5% |
| Other income | 22 Cr | 28 Cr | 28 Cr | 37 Cr | 38 Cr | 64 Cr | 61 Cr | 40 Cr | 55 Cr | 53 Cr | 44 Cr | 49 Cr |
| Interest | 111 Cr | 113 Cr | 119 Cr | 116 Cr | 118 Cr | 110 Cr | 115 Cr | 108 Cr | 110 Cr | 113 Cr | 119 Cr | 120 Cr |
| Depreciation | 163 Cr | 167 Cr | 190 Cr | 177 Cr | 185 Cr | 185 Cr | 211 Cr | 215 Cr | 218 Cr | 219 Cr | 224 Cr | 235 Cr |
| Profit before tax | 379 Cr | 363 Cr | 368 Cr | 430 Cr | 557 Cr | 536 Cr | 516 Cr | 583 Cr | 675 Cr | 682 Cr | 722 Cr | 799 Cr |
| Tax % | 34.4% | 30.0% | 29.8% | 26.6% | 29.0% | 29.2% | 19.6% | 24.3% | 26.8% | 24.3% | 23.6% | 23.6% |
| Net profit | 249 Cr | 254 Cr | 258 Cr | 316 Cr | 396 Cr | 379 Cr | 415 Cr | 441 Cr | 494 Cr | 516 Cr | 551 Cr | 610 Cr |
| EPS (₹) | ₹16.20 | ₹17.06 | ₹17.65 | ₹21.23 | ₹26.34 | ₹25.89 | ₹27.10 | ₹30.10 | ₹33.19 | ₹34.94 | ₹36.82 | ₹40.39 |
Profit & loss (annual)
Annual · last column is TTM · ₹ Cr · tap + to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|
| Sales | 9,617 Cr | 11,247 Cr | 10,560 Cr | 14,663 Cr | 16,612 Cr | 19,059 Cr | 21,794 Cr | 25,229 Cr | Sign in for TTM |
| Operating expenses (approx.) | 8,554 Cr | 9,660 Cr | 9,423 Cr | 12,478 Cr | 14,563 Cr | 16,669 Cr | 18,772 Cr | 21,459 Cr | Sign in for TTM |
| EBITDA | 1,064 Cr | 1,587 Cr | 1,137 Cr | 2,185 Cr | 2,050 Cr | 2,391 Cr | 3,022 Cr | 3,769 Cr | Sign in for TTM |
| OPM % | 11.1% | 14.1% | 10.8% | 14.9% | 12.3% | 12.5% | 13.9% | 14.9% | Sign in for TTM |
| Other income | 31 Cr | 27 Cr | 45 Cr | 78 Cr | 90 Cr | 106 Cr | 200 Cr | 192 Cr | Sign in for TTM |
| Interest | 327 Cr | 533 Cr | 449 Cr | 379 Cr | 381 Cr | 449 Cr | 459 Cr | 450 Cr | Sign in for TTM |
| Depreciation | 396 Cr | 620 Cr | 573 Cr | 601 Cr | 615 Cr | 687 Cr | 758 Cr | 876 Cr | Sign in for TTM |
| Profit before tax | 374 Cr | 657 Cr | 221 Cr | 1,585 Cr | 1,101 Cr | 1,381 Cr | 2,039 Cr | 2,661 Cr | Sign in for TTM |
| Tax % | 46.4% | 34.3% | 38.2% | 30.1% | 23.3% | 32.3% | 26.2% | 24.7% | Sign in for TTM |
| Net profit | 200 Cr | 432 Cr | 137 Cr | 1,108 Cr | 845 Cr | 935 Cr | 1,505 Cr | 2,003 Cr | Sign in for TTM |
| EPS (₹) | ₹16.97 | ₹32.70 | ₹10.74 | ₹73.42 | ₹56.97 | ₹62.50 | ₹100.56 | ₹135.04 | Sign in for TTM |
| Dividend payout % | — | — | — | 3.9% | 30.5% | 23.6% | 18.5% | 14.6% | Sign in for TTM |
Trailing twelve months totals and margin rows
Balance sheet
Annual · ₹ Cr · tap + rows to expand
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Equity capital | 70 Cr | 70 Cr | 70 Cr | 72 Cr | 72 Cr | 72 Cr | 72 Cr | 72 Cr |
| Reserves | 3,264 Cr | 3,262 Cr | 3,262 Cr | 5,565 Cr | 6,125 Cr | 6,864 Cr | 8,140 Cr | 9,408 Cr |
| Borrowings | 3,450 Cr | — | — | — | 2,710 Cr | 3,162 Cr | 5,275 Cr | 5,659 Cr |
| Other liabilities | 2,264 Cr | 8,007 Cr | 8,086 Cr | 7,577 Cr | 5,186 Cr | 6,271 Cr | 6,729 Cr | 6,564 Cr |
| Total liabilities | 9,183 Cr | 11,338 Cr | 11,417 Cr | 13,214 Cr | 14,428 Cr | 16,753 Cr | 20,657 Cr | 22,197 Cr |
| Fixed assets (net) | 4,594 Cr | — | — | — | 7,432 Cr | 8,541 Cr | 9,816 Cr | 11,039 Cr |
| CWIP | 822 Cr | — | — | — | 602 Cr | 845 Cr | 771 Cr | 992 Cr |
| Investments | 468 Cr | — | — | — | 578 Cr | 990 Cr | 2,490 Cr | 2,181 Cr |
| Loans & advances | 8 Cr | — | — | — | 6 Cr | 5 Cr | 5 Cr | 2 Cr |
| Inventories | 585 Cr | — | — | — | 390 Cr | 460 Cr | 481 Cr | 542 Cr |
| Trade receivables | 1,023 Cr | — | — | — | 2,234 Cr | 2,515 Cr | 3,016 Cr | 3,485 Cr |
| Cash & bank | 283 Cr | — | — | — | 433 Cr | 506 Cr | 578 Cr | 811 Cr |
| Other assets | 1,401 Cr | 11,338 Cr | 11,417 Cr | 13,214 Cr | 2,753 Cr | 2,893 Cr | 3,501 Cr | 3,145 Cr |
| Total assets | 9,183 Cr | 11,338 Cr | 11,417 Cr | 13,214 Cr | 14,428 Cr | 16,753 Cr | 20,657 Cr | 22,197 Cr |
Cash flows
Annual · ₹ Cr · tap + rows to expand · last column includes FCF
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | — | — | — | 1,616 Cr | 1,377 Cr | 1,920 Cr | 2,136 Cr | 2,856 Cr |
| Cash from investing | — | — | — | -791 Cr | -857 Cr | -1,537 Cr | -3,381 Cr | -2,148 Cr |
| Cash from financing | — | — | — | -768 Cr | -633 Cr | -311 Cr | 1,317 Cr | -478 Cr |
| Net cash flow | — | — | — | 57 Cr | -113 Cr | 72 Cr | 73 Cr | 230 Cr |
| Free cash flow (OCF − Capex) | — | — | — | 958 Cr | 249 Cr | 784 Cr | 424 Cr | 894 Cr |
Ratios
Ratios as reported or derived per annual period.
| Metric | Mar 2019BSE balance sheet (this exchange's own filing had none for this period) | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| ROCE % | 21.1% | 35.7% | 20.1% | 34.8% | 16.0% | 17.5% | 17.9% | 19.9% |
| ROE % | 7.1% | 13.7% | 4.5% | 18.7% | 12.5% | 12.3% | 16.7% | 19.5% |
| Debtor days | 39 | — | — | — | 49 | 48 | 50 | 50 |
| Inventory days | 129 | — | — | — | 62 | 68 | 64 | 65 |
| Days payable | 158 | — | — | — | 305 | 352 | 296 | 270 |
| Cash conversion cycle | 10 | — | — | — | -194 | -236 | -182 | -154 |
| Debt / equity | 1.04 | 0.00 | — | — | 0.44 | 0.46 | 0.64 | 0.60 |
| Current ratio | 1.17 | — | — | — | 1.30 | 1.13 | 1.54 | 1.06 |
| Net debt / EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 1.11 | 1.11 | 1.55 | 1.29 |
Compare with peers
Loading peers…